Alliancebernstein L.P. Exact Sciences Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Exact Sciences Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 960,592 shares of EXAS stock, worth $47.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

960,592

Previous 958,369 0.23%

Holding current value

$47.4 Million

Previous $40.5 Million 61.53%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $94,321 - $157,455	2,223 Added 0.23%	960,592 $65.4 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $36.3 Million - $65.3 Million	878,674 Added 1102.55%	958,369 $40.5 Million
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $1.96 Million - $2.57 Million	-34,897 Reduced 30.45%	79,695 $5.5 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $2.23 Million - $2.85 Million	37,698 Added 49.03%	114,592 $8.48 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $6,000 - $9,012	91 Added 0.12%	76,894 $5.25 Million
Q2 2023 Aug 15, 2023	SELL	$62.68 - $95.05 $44,001 - $66,725	-702 Reduced 0.91%	76,803 $7.21 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $394,980 - $592,344	-8,370 Reduced 9.75%	77,505 $5.26 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $96,330 - $168,698	3,174 Added 3.84%	85,875 $4.25 Million
Q3 2022 Nov 15, 2022	SELL	$31.97 - $49.37 $11,221 - $17,328	-351 Reduced 0.42%	82,701 $2.69 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $178,085 - $381,226	5,001 Added 6.41%	83,052 $3.27 Million
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $83,289 - $119,435	-1,447 Reduced 1.82%	78,051 $5.46 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $400,345 - $555,954	-5,522 Reduced 6.49%	79,498 $6.19 Million
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $152,415 - $209,520	-1,689 Reduced 1.95%	85,020 $8.12 Million
Q2 2021 Jul 30, 2021	BUY	$93.66 - $139.27 $217,478 - $323,384	2,322 Added 2.75%	86,709 $10.8 Million
Q1 2021 May 06, 2021	SELL	$116.57 - $155.01 $19,583 - $26,041	-168 Reduced 0.2%	84,387 $11.1 Million
Q4 2020 Feb 08, 2021	BUY	$99.61 - $142.12 $117,340 - $167,417	1,178 Added 1.41%	84,555 $11.2 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $172,820 - $241,763	2,370 Added 2.93%	83,377 $8.5 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $297,314 - $494,635	5,333 Added 7.05%	81,007 $7.04 Million
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $599,047 - $1.65 Million	-15,806 Reduced 17.28%	75,674 $4.39 Million
Q4 2019 Feb 18, 2020	SELL	$77.66 - $99.74 $24.7 Million - $31.7 Million	-317,515 Reduced 77.63%	91,480 $8.46 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $97.3 Million - $132 Million	-1,076,864 Reduced 72.47%	408,995 $37 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $30.1 Million - $39.6 Million	-335,881 Reduced 18.44%	1,485,859 $175 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $27.6 Million - $42.9 Million	-445,058 Reduced 19.63%	1,821,740 $158 Million
Q4 2018 Feb 13, 2019	SELL	$56.04 - $82.66 $640,257 - $944,390	-11,425 Reduced 0.5%	2,266,798 $143 Million
Q3 2018 Nov 08, 2018	SELL	$48.29 - $80.6 $10 Million - $16.7 Million	-207,259 Reduced 8.34%	2,278,223 $180 Million
Q2 2018 Aug 13, 2018	SELL	$37.84 - $69.96 $7.39 Million - $13.7 Million	-195,423 Reduced 7.29%	2,485,482 $149 Million
Q1 2018 May 14, 2018	BUY	$39.82 - $57.53 $97.3 Million - $141 Million	2,442,295 Added 1023.55%	2,680,905 $108 Million
Q4 2017 Feb 13, 2018	BUY	$46.49 - $60.51 $110,181 - $143,408	2,370 Added 1.0%	238,610 $12.5 Million
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $8.75 Million - $11.1 Million	236,240	236,240 $11.1 Million

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Exact Sciences Corp Transaction History